secwatch.observer — SEC 8-K summary
======================================

Issuer:     Dare Bioscience, Inc. (DARE)
CIK:        0001401914
Form:       8-K
Filed at:   2025-06-25T23:59:59+00:00
Accession:  0001641172-25-016374
Event type: other_material
Sentiment:  negative
Materiality: 0.75
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Nasdaq panel approves Dare Bioscience's compliance plan; deadline Aug 12, 2025
------------------------------------------------------------------------------

- Panel approved modified plan to regain compliance with Nasdaq Listing Rules 5550(b)(1) (≥$2.5M equity) or 5550(b)(2) (≥$35M MVLS).
- Must demonstrate compliance by July 31, 2025; conditional listing ends August 12, 2025.
- If plan fails, Nasdaq may delist common stock before August 12, 2025.
- Company has been non-compliant with Rule 5550(b) since August 2024.
- No assurances given that compliance will be achieved by the deadlines.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1401914/000164117225016374/0001641172-25-016374-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1401914/000164117225016374/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-016374

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer